Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

In a recent study posted to the medRxiv pre-print server, researchers assessed the effectiveness of the Pfizer–BioNTech BNT162b2 coronavirus disease 2019 (COVID-19) vaccine in the seven million United Kingdom (UK) adults who were eligible to receive booster shots between 16 September and 16 December 2021.

7 Jun 2022

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

In a recent investigation published in the Annals of Internal Medicine journal, scientists demonstrated the positive impacts of molnupiravir among severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patients and the healthcare sector apart from lowering disease-linked deaths and hospitalizations in at-risk cohorts.

7 Jun 2022

Gastrointestinal complications caused by SARS-CoV-2

scientists discuss the gastrointestinal complications associated with COVID-19.

7 Jun 2022

How do viruses evolve to infect new hosts?

Researchers discuss how protein thermostability prevents the misfolding of viral proteins from being heated.

7 Jun 2022

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

People with HIV have a higher rate of breakthrough COVID-19 infections after vaccination, compared to people without HIV, according to findings from a study led by researchers at the Johns Hopkins Bloomberg School of Public Health.

7 Jun 2022

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

7 Jun 2022

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

A study co-led by the Universities of Oxford, Birmingham and Southampton and the UK Health Security Agency (UKHSA), published in Lancet Oncology today by the UK Coronavirus Cancer Evaluation Project, has found that while COVID-19 vaccination is effective in most cancer patients, the level of protection against COVID-19 infection, hospitalization and death offered by the vaccine is less than in the general population and vaccine effectiveness wanes more quickly.

7 Jun 2022

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

Researchers evaluated the impact of breakthrough infections with SARS-CoV-2 Omicron BA.1 sublineage on SARS-CoV-2 variants of concern neutralization and memory B lymphocytes formation among BNT162b2 vaccinees.

7 Jun 2022

Molecular modeling techniques describe the process of interaction between nanotubes and the main structures of SARS-CoV-2

Researchers assessed the interactions between carbon nanotubes and SARS-CoV-2.

7 Jun 2022

De novo-designed mini-protein against SARS-CoV-2

Researchers characterized truncated forms of LCB1, a de novo-designed mini-protein, against SARS-CoV-2.

7 Jun 2022

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

Researchers assessed the impact of COVID-19 on influenza vaccination.

7 Jun 2022

The risk of developing incident diabetes following hospital discharge or at least 28 days after COVID-19 diagnosis

Researchers evaluated the risk of developing incident diabetes mellitus post-acute phase of COVID-19.

7 Jun 2022

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Researchers observed SARS-CoV-2 seroconversion in lactating cows.

7 Jun 2022

Omicron lineage spike proteins use ACE2 receptors more efficiently

A recent study posted to the bioRxiv* preprint server demonstrated various traits, including the entry pathways and sensitivity to vaccination-elicited antibody responses by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants.

7 Jun 2022

Sarbecovirus pathogenesis regulated by a multitrait locus

In a recent study posted to the bioRxiv* preprint server, the authors demonstrated that the sarbecovirus pathogenesis was regulated by a multitrait locus.

7 Jun 2022

Profound neuroinflammation associated with long COVID

Around 36 to 53% of coronavirus disease 2019 (COVID-19) patients develop persistent chronic symptoms, often referred to as long COVID or PASC.

7 Jun 2022

Post-COVID smell and taste dysfunction associated with better recovery in long-COVID

In a recent study posted to the medRxiv* pre-print server, Austrian researchers performed a multi-cohort analysis to investigate the slow resolution of subjective olfactory dysfunction (OD) and accompanying taste disorder in coronavirus disease 2019 (COVID-19) inpatients and outpatients.

7 Jun 2022

Study says 460k of first million recorded US COVID deaths caused by variants

In a recent research paper posted to the medRxiv* preprint server, scientists from Yale School of Public Health analyzed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-linked deaths in the United States (US).

7 Jun 2022

Age exacerbates COVID neuroimmunological symptoms

In a recent study posted to the bioRxiv* pre-print server, researchers at the University of Illinois at Chicago investigated whether aging exacerbated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection-induced neuropsychiatric disorders.

6 Jun 2022

Monkeypox virus transmission via sexual contact

A new study discusses the transmission of monkeypox through sexual contact.

6 Jun 2022

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

OpenSAFELY study shows the effectiveness of Pfizer COVID booster doses

Study finds added benefits of molnupiravir for non-hospitalized COVID-19 patients

Gastrointestinal complications caused by SARS-CoV-2

How do viruses evolve to infect new hosts?

People with HIV are at greater risk of breakthrough COVID-19 infections after vaccination

Com-COV 3 study focuses on assessing a third dose booster vaccination for young people aged 12 to 15

COVID-19 vaccination may offer less effective and shorter-lasting protection for some cancer patients

The effect of Omicron breakthrough infection on the magnitude and breadth of serum neutralizing activity and memory B cells among BNT162b2 vaccinees

Molecular modeling techniques describe the process of interaction between nanotubes and the main structures of SARS-CoV-2

De novo-designed mini-protein against SARS-CoV-2

Influenza vaccination rates of health and aged care facility staff during the COVID-19 pandemic

The risk of developing incident diabetes following hospital discharge or at least 28 days after COVID-19 diagnosis

Natural serological evidence of SARS-CoV-2 infection in lactating cows

Omicron lineage spike proteins use ACE2 receptors more efficiently

Sarbecovirus pathogenesis regulated by a multitrait locus

Profound neuroinflammation associated with long COVID

Post-COVID smell and taste dysfunction associated with better recovery in long-COVID

Study says 460k of first million recorded US COVID deaths caused by variants

Age exacerbates COVID neuroimmunological symptoms

Monkeypox virus transmission via sexual contact

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in